Lcnb Corp Baxter International Inc Transaction History

Lcnb Corp

$267 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$49.7 - $57.71 $103,376 - $120,036	-2,080 Reduced 25.75%	5,998 $305,000
Q2 2022 Aug 12, 2022	BUY	$63.83 - $80.0 $9,765 - $12,240	153 Added 1.93%	8,078 $519,000
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $72,239 - $84,083	940 Added 13.46%	7,925 $615,000
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $17,523 - $20,489	-235 Reduced 3.25%	6,985 $600,000
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $6,639 - $7,524	-90 Reduced 1.23%	7,220 $581,000
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $7,638 - $8,603	-100 Reduced 1.35%	7,310 $617,000
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $7,539 - $8,236	-100 Reduced 1.33%	7,410 $595,000
Q2 2020 Aug 12, 2020	SELL	$78.66 - $94.14 $31,464 - $37,656	-400 Reduced 5.06%	7,510 $647,000
Q1 2020 May 11, 2020	SELL	$71.57 - $93.3 $2,862 - $3,732	-40 Reduced 0.5%	7,910 $642,000
Q4 2019 Feb 10, 2020	SELL	$76.7 - $88.45 $11,505 - $13,267	-150 Reduced 1.85%	7,950 $665,000
Q3 2019 Nov 08, 2019	BUY	$81.4 - $89.78 $3,663 - $4,040	45 Added 0.56%	8,100 $709,000
Q2 2019 Aug 01, 2019	SELL	$73.44 - $82.41 $6,609 - $7,416	-90 Reduced 1.1%	8,055 $660,000
Q4 2018 Feb 19, 2019	BUY	$61.45 - $77.8 $921 - $1,167	15 Added 0.18%	8,145 $536,000
Q3 2018 Nov 09, 2018	SELL	$70.71 - $77.75 $8,485 - $9,330	-120 Reduced 1.45%	8,130 $627,000
Q2 2018 Aug 13, 2018	BUY	$63.43 - $75.41 $136,691 - $162,508	2,155 Added 35.36%	8,250 $609,000
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $6,145 - $6,605	-100 Reduced 1.61%	6,095 $394,000
Q3 2017 Nov 13, 2017	SELL	$59.5 - $64.61 $1,487 - $1,615	-25 Reduced 0.4%	6,195 $389,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,220	6,220 $377,000

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account